تفاعل #157984

ord-33004f25daeb4eaa95b6c15a34f6c655

المذيبات

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    أخرىThe aqueous phase is removed
  2. 2
    استخلاصextracted with ethyl acetate
  3. 3
    تجفيفThe combined organic phases are dried over sodium sulfate
  4. 4
    ترشيحThe solids are filtered off
  5. 5
    workup.DISTILLATIONthe solvent is distilled off
  6. 6
    أخرىThe residue is purified by chromatography

الإجراء التجريبي

To a solution of 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid (E, 160 mg) in dichloromethane (5 ml) are added, at room temperature, 2-chlorocyclohexanol (57 mg), 4-dimethylaminopyridine (4 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (94 mg). The mixture is stirred overnight, and water is then added. The aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulfate. The solids are filtered off and the solvent is distilled off. The residue is purified by chromatography. This gives 2-chlorocyclohexyl 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate (100 mg, 50%).

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08822693B2uspto-grants-2014_09